About this trial
The purpose of the COMPLEX Registry is to prospectively and retrospectively collect baseline, clinical and procedural data of patients who have undergone PCI or CABG for complex and/ or calcified chronic CAD, irrespective of clinical presentation as well as to prospectively collect data about their clinical outcomes. The outcomes will be compared in different clinical subgroups (e.g. PCI vs. CABG). The impact of current PCI techniques/ devices, but also CABG strategies in different clinical settings and coronary artery lesions on cardiovascular outcomes will be assessed.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Subject >18 years of age
Individuals presenting with chronic, complex and/or calcified CAD and requiring PCI or CABG
Long and/ or heavily calcified coronary lesions
In-stent restenosis
Disqualifiers
Patient is <18 years of age
Patient unwilling or unable to provide informed consent
Patients with no complex and calcified CAD
Trial population
In an all-comers design, virtually any CAD patient with complex and/ or calcified coronary artery disease treated with PCI or CABG at the Heart Center of the Luzerner Kantonsspital (LUKS) and giving consent may be included.
Trial design
Cohort
Prospective
Treatments tested in this trial
Impact of current PCI techniques/ devices in complex coronary artery lesions
DeviceTo evaluate the impact of current PCI techniques/devices, but also CABG strategies, in patients with complex coronary artery lesions
Treatment groups
Trial outcomes
Primary outcomes
Rate of Major adverse cardiac and cerebrovascular events (MACCE)
Secondary outcomes
Rate of combination of major adverse cardiac and cerebrovascular events (MACCE)
Rate of acute vessel closure
Rate of target vessel revascularization (TVR)
Rate of target lesion revascularization (TLR)
Sponsors and contacts
Click on the lead sponsor to view all of their trials.